Trinity Legacy Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
Trinity Legacy Partners's AMGN Position: Q2 2026 in Review
Trinity Legacy Partners increased its Amgen (AMGN) stake by 6.4% in Q2 2026, buying an estimated $378K and bringing the position to 18,358 shares worth $6.82M. The position accounts for 1.36% of the portfolio, ranked #28.
Trinity Legacy Partners first reported a position in AMGN in Q4 2021 and has held it in 15 quarters since. 1,278 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Trinity Legacy Partners held 18,358 shares of Amgen worth $6.82M as of Q2 2026.
- Trinity Legacy Partners bought 1,105 Amgen shares in Q2 2026, an estimated $378K.
- Amgen made up 1.36% of Trinity Legacy Partners's portfolio in Q2 2026, its #28 holding.
- Trinity Legacy Partners first reported a position in Amgen in Q4 2021 and has held it in 15 quarters since.
- 1,278 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Trinity Legacy Partners's 13F filing for Q2 2026, filed 24 Jul 2026.